NASDAQ : FVAM
-$0.02 (-0.2%)
%
change: 0.0 | last:
change: 0.0 | last:
change: 0.0 | last:
change: 0.0 | last:
change: 0.0 | last:
-
-
change: 0.0 | last:
-
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2022-08-11 | 2. | 10.0 | 5.50% |
| 2022-08-11 | 2. | 10.0 | 5.40% |
| 2022-08-11 | 2. | 10.0 | 0.00% |
| 2022-08-11 | 2. | 10.0 | 0.00% |
| 2022-08-11 | 2. | 10.0 | 5.40% |
| 2022-08-11 | 2. | 10.0 | 5.40% |
| 2022-08-11 | 2. | 10.0 | 0.00% |
| 2022-03-08 | Sculptor Enhanced Master Fund, Ltd. | 17191.0 | 0.20% |
| 2022-03-08 | Sculptor Capital Holding II LLC | 497.38K | 5.77% |
| 2022-03-08 | Sculptor Capital Management, Inc. | 497.38K | 5.77% |
| 2022-03-08 | Sculptor Master Fund, Ltd. | 392.45K | 4.55% |
| 2022-03-08 | Sculptor Capital Holding Corp. | 497.38K | 5.77% |
| 2022-03-08 | Sculptor Capital LP | 497.38K | 5.77% |
| 2022-03-08 | Sculptor Capital II LP | 497.38K | 5.77% |
| 2022-03-08 | Sculptor Special Funding, LP | 392.45K | 4.55% |
| 2022-03-08 | Sculptor Credit Opportunities Master Fund, Ltd. | 27631.0 | 0.32% |
| 2022-03-08 | Sculptor SC II LP | 60106.0 | 0.70% |
| 2022-02-14 | Paul J. Glazer | 429.83K | 4.99% |
| 2022-02-14 | Alyeska Investment Group, L.P. | 600K | 6.96% |
| 2022-02-14 | Alyeska Fund GP, LLC | 600K | 6.96% |
| 2022-02-14 | Anand Parekh | 600K | 6.96% |
| 2022-02-14 | Glazer Capital, LLC | 429.83K | 4.99% |
| 2022-02-11 | Slate Path Capital LP | 500K | 5.80% |
| 2021-10-15 | Saba Capital Management GP, LLC | 567.2K | 6.60% |
| 2021-10-15 | Saba Capital Management, L.P. | 567.2K | 6.60% |
| 2021-10-15 | Boaz R. Weinstein | 567.2K | 6.60% |
| 2021-03-05 | Biotechnology Value Fund, L.P. | 260.59K | 3.00% |
| 2021-03-05 | BVF Partners L.P. | 500K | 5.80% |
| 2021-03-05 | BVF Partners OS Ltd. | 34291.0 | 1.00% |
| 2021-03-05 | BVF GP HOLDINGS LLC | 454.58K | 5.30% |
| 2021-03-05 | BVF Inc. | 500K | 5.80% |
| 2021-03-05 | Mark N. Lampert | 500K | 5.80% |
| 2021-03-05 | BVF I GP LLC | 260.59K | 3.00% |
| 2021-03-05 | Biotechnology Value Fund II, L.P. | 193.99K | 2.30% |
| 2021-03-05 | BVF II GP LLC | 193.99K | 2.30% |
| 2021-03-05 | Biotechnology Value Trading Fund OS LP | 34291.0 | 1.00% |
| 2021-02-16 | Alyeska Investment Group, L.P. | 600K | 7.00% |
| 2021-02-16 | Rajeev Shah | 750K | 8.70% |
| 2021-02-16 | RA Capital Healthcare Fund, L.P. | 682.48K | 7.90% |
| 2021-02-16 | Anand Parekh | 600K | 7.00% |
| 2021-02-16 | Alyeska Fund GP, LLC | 600K | 7.00% |
| 2021-02-16 | RA Capital Management, L.P. | 750K | 8.70% |
| 2021-02-16 | Peter Kolchinsky | 750K | 8.70% |
| 2021-02-16 | Glazer Capital, LLC | 492.01K | 5.70% |
| 2021-02-16 | Paul J. Glazer | 492.01K | 5.70% |
| 2020-10-23 | Michael Platt | 600K | 7.20% |
| 2020-10-23 | BlueCrest Capital Management Limited | 600K | 7.20% |
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2021-12-31 | $9.85 | 10.68M | $105.25M | $331.27K | -$ | $104.92M |
| 2020-12-31 | $10.17 | 7.44M | $75.72M | $1.14M | -$ | $74.57M |
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2022-06-30 | $9.90 | 10.66M | $105.56M | $674.14K | $1M | $105.89M |
| 2022-03-31 | $9.85 | 10.68M | $105.25M | $989.86K | $1M | $105.26M |
| 2021-12-31 | $9.85 | 10.32M | $101.66M | $331.27K | -$ | $101.32M |
| 2021-09-30 | $9.82 | 10.32M | $101.35M | $650.4K | -$ | $100.7M |
| 2021-06-30 | $9.97 | 2.43M | $24.22M | $785.25K | -$ | $23.43M |
| 2021-03-31 | $9.99 | 2.43M | $24.27M | $976.55K | -$ | $23.29M |
| 2020-12-31 | $10.17 | 2M | $20.34M | $1.14M | -$ | $19.2M |
| 2020-09-30 | $10.00 | 2M | $20M | $288.7K | $300K | $20.01M |